| Pegylated interferon‐α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data P Glue, JWS Fang, R Rouzier‐Panis, C Raffanel, R Sabo, SK Gupta, ... Clinical Pharmacology & Therapeutics 68 (5), 556-567, 2000 | 725 | 2000 |
| Model‐based drug development RL Lalonde, KG Kowalski, MM Hutmacher, W Ewy, DJ Nichols, ... Clinical Pharmacology & Therapeutics 82 (1), 21-32, 2007 | 511 | 2007 |
| Flumazenil provocation of panic attacks: evidence for altered benzodiazepine receptor sensitivity in panic disorder DJ Nutt, P Glue, C Lawson, S Wilson Archives of General Psychiatry 47 (10), 917-925, 1990 | 383 | 1990 |
| A dose‐ranging study of pegylated interferon alfa‐2b and ribavirin in chronic hepatitis C P Glue, R Rouzier‐Panis, C Raffanel, R Sabo, SK Gupta, M Salfi, ... Hepatology 32 (3), 647-653, 2000 | 325 | 2000 |
| The clinical pharmacology of ribavirin. P Glue Seminars in liver disease 19, 17-24, 1999 | 299 | 1999 |
| Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis Y Xu, M Hackett, G Carter, C Loo, V Gálvez, N Glozier, P Glue, K Lapidus, ... International Journal of Neuropsychopharmacology 19 (4), pyv124, 2016 | 249 | 2016 |
| Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial DM Simpson, G Schifitto, DB Clifford, TK Murphy, E Durso-De Cruz, ... Neurology 74 (5), 413-420, 2010 | 237 | 2010 |
| Placebo‐controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression CK Loo, V Gálvez, E O'Keefe, PB Mitchell, D Hadzi‐Pavlovic, J Leyden, ... Acta Psychiatrica Scandinavica 134 (1), 48-56, 2016 | 217 | 2016 |
| Population pharmacokinetic and pharmacodynamic analysis of ribavirin in patients with chronic hepatitis C JF Jen, P Glue, S Gupta, D Zambas, G Hajian Therapeutic drug monitoring 22 (5), 555-565, 2000 | 196 | 2000 |
| Ribavirin and interferon alfa‐2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions S Khakoo, P Glue, L Grellier, B Wells, A Bell, C Dash, I Murray‐Lyon, ... British journal of clinical pharmacology 46 (6), 563-570, 1998 | 168 | 1998 |
| Ketamine as a new treatment for depression: a review of its efficacy and adverse effects N Katalinic, R Lai, A Somogyi, PB Mitchell, P Glue, CK Loo Australian & New Zealand Journal of Psychiatry 47 (8), 710-727, 2013 | 166 | 2013 |
| Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166) MK Romach, P Glue, K Kampman, HL Kaplan, GR Somer, S Poole, ... Archives of General Psychiatry 56 (12), 1101-1106, 1999 | 165 | 1999 |
| Polyethylene glycol modified interferon therapy P Glue, DL Cutler, MB Affrime US Patent 5,908,621, 1999 | 162 | 1999 |
| Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine‐sensitive (es)‐nucleoside transporters SM Jarvis, JA Thorn, P Glue British journal of pharmacology 123 (8), 1587-1592, 1998 | 157 | 1998 |
| Optimal treatment of social phobia: systematic review and meta-analysis J Canton, KM Scott, P Glue Neuropsychiatric Disease and Treatment, 203-215, 2012 | 150 | 2012 |
| ‘Violence is not part of our job’: a thematic analysis of psychiatric mental health nurses’ experiences of patient assaults from a New Zealand perspective M Baby, P Glue, D Carlyle Issues in mental health nursing 35 (9), 647-655, 2014 | 147 | 2014 |
| Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology SL Preston, GL Drusano, P Glue, J Nash, SK Gupta, P McNamara Antimicrobial agents and chemotherapy 43 (10), 2451-2456, 1999 | 134 | 1999 |
| Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study A Tan, JT Brouwer, P Glue, R Van Leusen, RH Kauffmann, SW Schalm, ... Nephrology Dialysis Transplantation 16 (1), 193-195, 2001 | 122 | 2001 |
| Systematic review of cognitive development across childhood in Down syndrome: implications for treatment interventions T Patterson, CM Rapsey, P Glue Journal of Intellectual Disability Research 57 (4), 306-318, 2013 | 120 | 2013 |
| Unexpected effect of rifampin on the pharmacokinetics of linezolid: in silico and in vitro approaches to explain its mechanism K Gandelman, T Zhu, OA Fahmi, P Glue, K Lian, RS Obach, B Damle The Journal of Clinical Pharmacology 51 (2), 229-236, 2011 | 119 | 2011 |
